Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosis

References

• Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod 1991;6:544–549.
   PubMed Web of Science ®Google Scholar
• Moen MH, Schei B. Epidemiology of endometriosis in a Norwegian county. Acta Obstet Gynecol Scand 1997;76:559–562.
   PubMed Web of Science ®Google Scholar
• Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 2004;18:177–200.
   PubMed Web of Science ®Google Scholar
• Witz CA, Burns WN. Endometriosis and infertility: is there a cause and effect relationship? Gynecol Obstet Invest 2002;53(Suppl 1):2–11.
   PubMedGoogle Scholar
• Simpson JL, Elias S, Malinak LR, Buttram VC Jr, Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980;137:327–331.
   PubMed Web of Science ®Google Scholar
• Simoens S, Hummelshoj L, D'Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 2007;13:395–404.
   PubMed Web of Science ®Google Scholar
• Allen C, Hopewell S, Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2005: CD004753.
   Google Scholar
• Hoshiai H, Terakawa N. Novel therapeutic targets for GnRH analogues in the treatment of endometriosis and current approaches to optimizing GnRH analogue therapy. Introduction. Gynecol Obstet Invest 2008;66(Suppl 1):1–2.
   Google Scholar
• Nawathe A, Patwardhan S, Yates D, Harrison GR, Khan KS. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008;115:818–822.
   PubMed Web of Science ®Google Scholar
• Redwine DB. Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease. Fertil Steril 1991;56:628–634.
   PubMed Web of Science ®Google Scholar
• Wheeler JM, Malinak LR. Recurrent endometriosis: incidence, management, and prognosis. Am J Obstet Gynecol 1983;146:247–253.
   PubMed Web of Science ®Google Scholar
• Evers JL, Dunselman GA, Land JA, Bouckaert PX. Is there a solution for recurrent endometriosis? Br J Clin Pract Suppl 1991;72:45–50; discussion 51–53.
   PubMedGoogle Scholar
• Renner SP, Rix S, Lermann J, Hildebrandt T, Strissel P, Thiel FC, Oppelt P, Beckmann MW, Fasching PA. Preoperative pain and recurrence risk in patients with peritoneal endometriosis. Gynecol Endocrinol, in press.
   Google Scholar
• Stratton P, Sinaii N, Segars J, Koziol D, Wesley R, Zimmer C, Winkel C, Nieman LK. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol 2008;111:88–96.
   PubMed Web of Science ®Google Scholar
• Horowitz SH. The diagnostic workup of patients with neuropathic pain. Anesthesiol Clin 2007;25:699–708, v.
   Google Scholar
• Evans S, Moalem-Taylor G, Tracey DJ. Pain and endometriosis. Pain 2007;132(Suppl 1):S22–S25.
   Google Scholar
• Jarrell J, Brant R, Leung W, Taenzer P. Women's pain experience predicts future surgery for pain associated with endometriosis. J Obstet Gynaecol Can 2007;29:988–991.
   Google Scholar
• Berkley KJ, Dmitrieva N, Curtis KS, Papka RE. Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci USA 2004;101:11094–11098.
   PubMed Web of Science ®Google Scholar
• Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science 2005;308:1587–1589.
   PubMed Web of Science ®Google Scholar
• Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Hum Reprod 2006;21:3001–3007.
   PubMed Web of Science ®Google Scholar
• Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noel JC. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril 2006;86:1336–1343.
   PubMed Web of Science ®Google Scholar
• Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:240–264.
   PubMed Web of Science ®Google Scholar
• Vaught JL. Substance P antagonists and analgesia: a review of the hypothesis. Life Sci 1988;43:1419–1431.
   PubMed Web of Science ®Google Scholar
• Abbadie C, Brown JL, Mantyh PW, Basbaum AI. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 1996;70:201–209.
   PubMed Web of Science ®Google Scholar
• Honor P, Menning PM, Rogers SD, Nichols ML, Basbaum AI, Besson JM, Mantyh PW. Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J Neurosci 1999;19:7670–7678.
   Google Scholar
• Henry JL. Substance P and inflammatory pain: potential of substance P antagonists as analgesics. Agents Actions Suppl 1993;41:75–87.
   Google Scholar
• Hunt SP, Mantyh PW. The molecular dynamics of pain control. Nat Rev Neurosci 2001;2:83–91.
   PubMed Web of Science ®Google Scholar
• Patte-Mensah C, Kappes V, Freund-Mercier MJ, Tsutsui K, Mensah-Nyagan AG. Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways. J Neurochem 2003;86:1233–1246.
   Google Scholar
• Patte-Mensah C, Penning TM, Mensah-Nyagan AG. Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord. J Comp Neurol 2004;477:286–299.
   Google Scholar
• Patte-Mensah C, Li S, Mensah-Nyagan AG. Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell Mol Life Sci 2004;61:2274–2284.
   Google Scholar
• Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA. Neurosteroid modulation of GABAA receptors. Prog Neurobiol 2003;71:67–80.
   PubMed Web of Science ®Google Scholar
• Bennett MI, Simpson KH. Gabapentin in the treatment of neuropathic pain. Palliat Med 2004;18:5–11.
   PubMed Web of Science ®Google Scholar
• Slonimski M, Abram SE, Zuniga RE. Intrathecal baclofen in pain management. Reg Anesth Pain Med 2004;29:269–276.
   PubMedGoogle Scholar
• Patte-Mensah C, Kibaly C, Mensah-Nyagan AG. Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception. Proc Natl Acad Sci USA 2005;102:9044–9049.
   Google Scholar
• Orsal AS, Blois S, Labuz D, Peters EM, Schaefer M, Arck PC. The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice. J Mol Med 2006;84:159–167.
   Google Scholar
• Treloar SA, Wicks J, Nyholt DR, Montgomery GW, Bahlo M, Smith V, Dawson G, Mackay IJ, Weeks DE, Bennett ST, et al Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 2005;77:365–376.
   PubMed Web of Science ®Google Scholar
• Treloar SA, Zhao ZZ, Le L, Zondervan KT, Martin NG, Kennedy S, Nyholt DR, Montgomery GW. Variants in EMX2 and PTEN do not contribute to risk of endometriosis. Mol Hum Reprod 2007;13:587–594.
   Google Scholar
• Zhao ZZ, Pollock PM, Thomas S, Treloar SA, Nyholt DR, Montgomery GW. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. Hum Reprod 2008;23:1661–1668.
   Google Scholar
• Montgomery GW, Nyholt DR, Zhao ZZ, Treloar SA, Painter JN, Missmer SA, Kennedy SH, Zondervan KT. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008;14:447–457.
   PubMed Web of Science ®Google Scholar
• Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434–442.
   PubMed Web of Science ®Google Scholar
• Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol 2008;111:1285–1292.
   PubMed Web of Science ®Google Scholar
• Sanger GJ. Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain. Br J Pharmacol 2004;141:1303–1312.
   PubMed Web of Science ®Google Scholar